Upgrades/Downgrades
Updated: 22-Sep-26 09:45 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| West Pharm | WST | Morgan Stanley | Equal-Weight » Overweight | $400 | |
| Quince Therapeutics | QNCX | Citizens | Mkt Perform » Mkt Outperform | $77 | |
| Plexus | PLXS | KeyBanc Capital Markets | Sector Weight » Overweight | $300 | |
| Omeros | OMER | Cantor Fitzgerald | Neutral » Overweight | $22 | |
| MetLife | MET | Piper Sandler | Neutral » Overweight | $110 | |
| Heritage Financial Corp. | HFWA | Brean Capital | Neutral » Buy | $33 | |
| Fifth Third | FITB | Citigroup | Neutral » Buy | $62 | |
| Eldorado Gold | EGO | BofA Securities | Underperform » Buy | $54 | |
| Brinker | EAT | Northcoast | Neutral » Buy | $275 | |
| Antero Midstream | AM | CapitalOne | Equal Weight » Overweight | $25 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Netflix | NFLX | HSBC Securities | Buy » Hold | $76 | |
| Valero Energy | VLO | Jefferies | Buy » Hold | $401 | |
| Marathon Petroleum | MPC | Jefferies | Buy » Hold | $413 | |
| Ericsson | ERIC | Morgan Stanley | Equal-Weight » Underweight | $9 | |
| Endava | DAVA | William Blair | Mkt Perform » Underperform | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Gulfport Energy | GPOR | Pickering Energy Partners | Outperform | ||
| Yesway | YSWY | William Blair | Outperform | ||
| Western Alliance Bancorp | WAL | Raymond James | Outperform | $90 | |
| W.P. Carey | WPC | Jefferies | Buy | $73 | |
| Terrestrial Energy | IMSR | Roth Capital | Buy | $15 | |
| SiriusPoint | SPNT | RBC Capital Mkts | Outperform | $30 | |
| Silver Bow Mining Corp | SBMT | Roth Capital | Buy | $11 | |
| Sandisk | SNDK | Rosenblatt | Buy | $2400 | |
| Rush Street Interactive | RSI | Stifel | Buy | $34 | |
| RenaissanceRe | RNR | RBC Capital Mkts | Sector Perform | $365 | |
| Pasqal Holding SA | PSQL | Canaccord Genuity | Buy | $16 | |
| Obsidian Therapeutics | OBX | Leerink Partners | Outperform | $32 | |
| Nintendo | NTDOY | BNP Paribas Exane | Neutral | ||
| NetEase | NTES | BNP Paribas Exane | Outperform | $180 | |
| Liftoff Mobile | LFTO | Piper Sandler | Neutral | $19 | |
| iRadimed | IRMD | Needham | Hold | ||
| GE HealthCare | GEHC | Needham | Buy | $93 | |
| Everest Group | EG | RBC Capital Mkts | Outperform | $455 | |
| Entera Bio | ENTX | Cantor Fitzgerald | Overweight | ||
| Deep Fission | FISN | Roth Capital | Buy | $18 | |
| Crane NXT | CXT | Jefferies | Buy | $60 | |
| Bilibili | BILI | BNP Paribas Exane | Outperform | $23 | |
| Butterfly Network | BFLY | Needham | Buy | $10 | |
| Williams Cos | WMB | CapitalOne | Overweight | $92 | |
| Kinder Morgan | KMI | CapitalOne | Equal Weight | $36 | |
| ONEOK | OKE | CapitalOne | Overweight | $110 | |
| Energy Transfer | ET | CapitalOne | Overweight | $26 | |
| Enterprise Products | EPD | CapitalOne | Equal Weight | $42 | |
| Williams Cos | WMB | Melius | Buy | $84 | |
| Kinder Morgan | KMI | Melius | Buy | $38 | |
| Energy Transfer | ET | Melius | Hold | $25 | |
| Enterprise Products | EPD | Melius | Hold | $42 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Radian Group | RDN | BTIG Research | Buy | $48 | |
| MGIC Investment | MTG | BTIG Research | Neutral | ||
| NMI Hldgs | NMIH | BTIG Research | Buy | $54 | |
| Essent Group | ESNT | BTIG Research | Neutral | ||
| Enact Holdings | ACT | BTIG Research | Neutral | ||
| Driven Brands | DRVN | Barclays | Equal Weight | $14 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Microsoft | MSFT | Oppenheimer | Outperform | $515 » $570 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |